Xi Tian
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
-
- Ferroptosis and cancer prognosis
- Renal cell carcinoma treatment
Papers in
-
- Ferroptosis and cancer prognosis 25
- Renal cell carcinoma treatment 22
-
- Epigenetics and DNA Methylation 9
- Renal and related cancers 7
- Co-authors
- Wenhao Xu (42 shared papers)Aihetaimujiang Anwaier (38 shared papers)Yuanyuan Qu (33 shared papers)Dingwei Ye (33 shared papers)Wangrui Liu (20 shared papers)Jiaqi Su (18 shared papers)Hailiang Zhang (22 shared papers)Guohai Shi (17 shared papers)
- Journals
- Frontiers in Oncology (4 papers)Frontiers in Immunology (3 papers)Rapid Communications in Mass Spectrometry (3 papers)Annals of Medicine (3 papers)Journal of Cellular and Molecular Medicine (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xi Tian
65 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 274
- Pulmonary and Respiratory Medicine 347
- Oncology 258
- Immunology 163
- Molecular Biology 500
Countries citing papers authored by Xi Tian
This map shows the geographic impact of Xi Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Tian more than expected).
Fields of papers citing papers by Xi Tian
This network shows the impact of papers produced by Xi Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Tian. The network helps show where Xi Tian may publish in the future.
Co-authors
The 25 scholars most cited alongside Xi Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 198 | |
| 2 | 2019 | 73 | |
| 3 | 2023 | 56 | |
| 4 | 2022 | 56 | |
| 5 | 2016 | 53 | |
| 6 | 2023 | 51 | |
| 7 | 2021 | 48 | |
| 8 | 2014 | 30 | |
| 9 | 2022 | 30 | |
| 10 | 2020 | 29 | |
| 11 | 2020 | 28 | |
| 12 | 2024 | 27 | |
| 13 | 2021 | 23 | |
| 14 | 2020 | 21 | |
| 15 | 2022 | 21 | |
| 16 | 2020 | 19 | |
| 17 | 2021 | 18 | |
| 18 | 2021 | 18 | |
| 19 | 2021 | 18 | |
| 20 | 2021 | 18 |
About Xi Tian
Xi Tian is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Immunology, having authored 76 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (25 papers), Renal cell carcinoma treatment (22 papers), Cancer Immunotherapy and Biomarkers (14 papers), Epigenetics and DNA Methylation (9 papers), Renal and related cancers (7 papers), Cancer, Lipids, and Metabolism (6 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Cancer Research (274 citations), Pulmonary and Respiratory Medicine (347 citations), Oncology (258 citations), Immunology (163 citations) and Molecular Biology (500 citations). Xi Tian has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Wenhao Xu, Aihetaimujiang Anwaier, Yuanyuan Qu, Dingwei Ye, Wangrui Liu, Jiaqi Su, Hailiang Zhang, Guohai Shi, Wenkai Zhu and Rongguo Zhang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, Rapid Communications in Mass Spectrometry, Annals of Medicine and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.